Detalhe da pesquisa
1.
Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2.
Antimicrob Agents Chemother
; 65(5)2021 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33649113
2.
Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001.
J Infect Dis
; 206(9): 1372-85, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22904336
3.
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.
Sci Transl Med
; 14(628): eabl7430, 2022 Jan 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34941423
4.
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19.
Curr Opin Virol
; 50: 17-22, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34271264
5.
Molnupiravir, an Oral Antiviral Treatment for COVID-19.
medRxiv
; 2021 Jun 17.
Artigo
Inglês
| MEDLINE | ID: mdl-34159342